Inventor
Chih-Chiang Tsou
Inventor
US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
C12NMicroorganisms or enzymes22%
C07DHeterocyclic compounds14%
PatentTitleYear
12,318,407Peptides displayed by HLA for use in immunotherapy against different types of cancers202512,290,530Peptides displayed by HLA for use in immunotherapy against different types of cancers202512,285,443Peptides displayed by HLA for use immunotherapy against different types of cancers202512,274,716Peptides displayed by HLA for use immunotherapy against different types of cancers202512,257,269Peptides displayed by HLA for use in immunotherapy against different types of cancers202512,246,039Peptides displayed by HLA for use in immunotherapy against different types of cancers202511,957,716Peptides displayed by HLA for use in immunotherapy against different types of cancers202411,951,132Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202411,918,607Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202411,801,264Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202311,779,606Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202311,376,281Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202211,369,636Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202211,357,797Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202211,197,892Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,179,418Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,154,576Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,147,839Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,147,838Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,141,437Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (20)· patent assignee history
2021–2025Based in US· patent location history
2022Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMATICS BIOTECHNOLOGIES GMBH | 20 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 19 | 2021–2025 |
| DE | 1 | 2022 |